Lunenfeld-Tanenbaum
Research Institute
Mount Sinai Hospital
Joseph & Wolf Lebovic Health Complex
60 Murray Street
Toronto, Ontario
M5T 3L9
Tel.: 416-586-4800 ext.4750
► The North American Wilms Tumor Study
► The Prosserman Centre for Population Health Research
► Web of Science Researcher ID
A-7439-2013
ASSOCIATE DIRECTOR OF POPULATION HEALTH
SENIOR INVESTIGATOR
Dr. Rayjean Hung is the Associate Director of Population Health and the Head of the Prosserman Centre for Population Health Research in the Institute. Dr. Hung joined the Institute in December of 2007, most recently from the University of California at Berkeley, where she also held the position of Visiting Researcher at the International Agency for Research on Cancer (IARC) in Lyon, France. She is a Professor in the Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto.
Dr. Hung research focuses on identifying individual molecular profiles related to cancer risk and progression. The overall goal is to reduce cancer death by early detection and improved patient management. Dr. Hung studies etiology and genetic architecture of adult and pediatric tumors and she integrates epidemiological and clinical data with molecular profile for comprehensive risk models in the population. She has been leading several large-scale international studies, including aero-digestive tract cancer, pancreatic cancer and Wilms tumor. Dr. Hung has substantial experience and expertise in analyzing data with high-dimensionality and published several high-impact papers on lung cancer genetics and cross-cancer pleiotropy. She has also led several seminal and highly-cited papers that quantified the risk factors for lung cancer beyond tobacco smoking. In addition, she has several long-standing collaborative projects with the World Health Organization and National Institutes of Health, and has advisory roles for several national and international organizations.
Related to children's health, in addition to Wilms tumor, Dr. Hung has been studying how early life determinants can affect children's health, and has been co-leading the follow-up efforts of Ontario Birth Study-Kids, which is designed to be a research platform for research topics related to developmental origin of health and diseases. Dr. Hung's research program helps to advance knowledge on why specific complex diseases occurs, identify high risk population for targeted screening for early detection and improved prognosis.
At a Glance
Dr. Hung holds the Tier 1 Canada Research Chair in Integrative Molecular Epidemiology, with expertise in the field of data science
Dr. Hung's research focuses on molecular and genomic epidemiology of cancer with ultimate goals of understanding how cancer develops and early detection
The current research topics include international studies of aerodigestive tract cancers and childhood cancers, as well as multi-omics integrative analysis
Major Research Activities
Dr. Hung's research focuses on molecular and genomic epidemiology of cancer with ultimate goals of understanding cancer etiology and mechanism, and contributing to primary and secondary prevention. The current research topics in Dr. Hung's team include international studies of aerodigestive tract cancers and childhood cancers, as well as multi-omics integrative analysis for risk modeling.
| About Us | |||||||||
| Senior Administration | |||||||||
| Research Committee | |||||||||
| Canada Research Continuity Emergency Fund | |||||||||
| Funding Opportunities | |||||||||
| CRCEF - Stage 3 | |||||||||
| Canada Research Chairs | |||||||||
| Technology Transfer | |||||||||
| Career Opportunities | |||||||||
